India recently made global headlines in medical treatment with a new blood group called Crib in a 38 -year -old woman from Kolar near Bangalore.

This discovery confirmed after months of research, doctors can deliver blood transfusions, rare blood disorders and patient safety.

What is cradle?

The newly identified blood group belongs to the cream system. Its name, “Krrib,” is for Crommer, India, Bangalore, where it was first discovered.

Dr. According to Prasathiba L, advisor in Transfusion Medicine at Sims Hospital, Chennai, “Human blood simple A, B, AB, and O Chart is far more complex than that we all know. Crib is a milestone discovery that still we need to know about blood groups.”

How was it found?

Rare blood type was identified in a 38 -year -old woman from South India. When the doctors of Rotary Bangalore TTK Blood Center tested her blood before surgery, they did not get a match.

His blood showed unusual reactions with all samples. The case was referred to for the International Blood Group Reference Laboratory (IBGRL) in the UK, which confirmed after 10 months of testing that it was an unknown blood group.

MGM Healthcare, Dr. of Chennai. “It was a surprising discovery. RTR was officially reported officially at the International Society of Blood Transfusion (ISBT) Congress in Milan, Italy in June 2025,” says Kuraral. It is a proud moment for India. “

How does it matter?

Blood transfers are often life-saving during surgery, pregnancies or accidents.

But patients with rare blood groups face a high risk if a compatible donor cannot be found quickly.

In such cases, hemolytic transfusion reactions may occur, where the patient’s immune system attacks the donor blood.

Dr. Prasathiba told indianoday.in, “Diseases like Thalassemia, sickle cell disease and applastic anemia require many infections. These patients already have a greater risk to develop complications when exposed to incompatible blood,” Dr. Prasathiba told indianoday.in.

Better registries need

The discovery of cradle has highlighted the gaps of India’s current blood donation and transfusion systems.

“The case shows why India immediately needs a strong global cooperation in a nation -wide rare blood donor registry and blood matching,” Dr. Kural says.

Beyond transfusion: The Big Picture

Doctors say that this success is not only about infection. There are wide implications for this:

• Immunogenenetics – Understanding how our immune system reacts to different blood types
• Improvement in limb transplantation
• Critical Care and Prenetal Diagnostics-Hai-Risk Treatments Reserve
• Emergency Preparation – Able to work quickly when rare cases appear

Dr. Prasathiba says, “Cradle discovery pushes us to reconsider blood typing in tertiary care centers. With more than 43 recognized blood group systems, these can be triggered by ignoring sub-failures like these, ignoring these such as these.”

Dr. The Quraral also says that if India continues to invest in immunology and genetics, it has the ability to become a global leader in transfusion medicine, which benefits patients not only here but worldwide.